XRAY
29
-8
LB
62
-9
MTCH
48
-2
HCA
70
-5
MDLZ
40
2
TXN
60
-6
STT
67
-9
NI
72
-5
SNA
42
-16
CTAS
61
-3
CMS
54
-3
TXT
65
-8
NWL
33
-6
ESS
28
-8
XRX
42
-7
LH
40
-9
MMC
61
-4
PFE
26
-17
CMCSA
46
-3
SWKS
53
-6
XRAY
29
-8
LB
62
-9
MTCH
48
-2
HCA
70
-5
MDLZ
40
2
TXN
60
-6
STT
67
-9
NI
72
-5
SNA
42
-16
CTAS
61
-3
CMS
54
-3
TXT
65
-8
NWL
33
-6
ESS
28
-8
XRX
42
-7
LH
40
-9
MMC
61
-4
PFE
26
-17
CMCSA
46
-3
SWKS
53
-6
Financhill
Back

Evolent Health 10K Form

Sell
12

EVH
Evolent Health

Last Price:
$7.36
Seasonality Move:
20.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVH News And Ratings

See the #1 stock for the next 7 days that we like better than EVH

EVH Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $-4M
Price / Cash Flow: 11.17
Annual Sales: $8.07
Price / Book: 1

Profitability

EPS (TTM): -1.23000
Net Income (TTM): $-109M
Gross Margin: $367.4M
Return on Equity: -10.73%
Return on Assets: -4.25%

Evolent Health Earnings Forecast

Key Evolent Health Financial Ratios

  • The Gross Profit Margin over the past 12 years for EVH is 14.38%.
  • The Selling, General & Administrative Expenses for EVH have been equal to 10.30% of Gross Profit Margin.
  • The Net Earning history of EVH is -2.41% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Evolent Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Technology
Sector: Health Care
Current Symbol: EVH
CUSIP: 30050B
Website: evolenthealth.com

Debt

Debt-to-Equity Ratio: 0.88
Current Ratio: 0.98
Quick Ratio: 0.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 13.54

EVH Technical Analysis vs Fundamental Analysis

Sell
12
Evolent Health (EVH) is a Sell

Is Evolent Health a Buy or a Sell?

  • Evolent Health stock is rated a Sell
    The current Evolent Health [EVH] share price is $8.00. The Score for EVH is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.